IP Library Patent Application 13132840
Patent Application
App. No. 13/132,840

Methods and Compositions to Facilitate Repair of Avascular Tissue

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/132,840
Abstract

Compositions and methods are provided for repairing damaged avascular zones, including intervertebral disc, in a patient in need thereof.

Claims (34)

1 . A method for treating a degenerative intervertebral disc in a patient in need thereof comprising:

harvesting stem cells from the patient in need thereof;

culturing the harvested stem cells under selective pressure that corresponds to the environment of a damaged intervertebral disc; and

implanting the selected stem cells in a posterior disc annulus of the degenerative intervertebral disc.

2 . The method of claim 1 wherein the selective pressure include culturing the harvested stem cells in from about 3 to about 10% oxygen.

3 . The method of claim 2 wherein the selective pressure includes culturing the harvested stem cells in from about 3 to about 7% oxygen.

4 . The method of claim 1 wherein the selective pressure include culturing the harvested stem cells in from about 2 to about 10% carbon dioxide.

5 . The method of claim 2 further comprising the selective pressure including culturing the harvested stem cells in from about 2 to about 10% carbon dioxide.

6 . The method of claim 1 further comprising:

harvesting NP cells from the patient in need thereof; and

co-culturing the NP cells with the harvested stem cells under selective pressure.

7 . The method of claim 1 wherein the stem cells are mesenchymal stem cells.

8 . The method of claim 1 further comprising:

harvesting platelets from the patient in need thereof; and

implanting the platelets prior to, during or after implanting selected stem cells;

wherein the implanting of both platelets and stem cells is in the posterior disc annulus.

9 . The method of claim 8 wherein the platelets are treated with thrombin and calcium chloride 1-7 days prior to implanting in posterior disc annulus.

10 . The method of claim 9 wherein the amount of thrombin is 28.56 U/ml and the amount of calcium chloride is 2.86 mg/ml.

11 . The method of claim 8 wherein the platelets are treated with thrombin, calcium chloride or its salts, thromboxane A2, adenosine triphosphate and arichidonate.

12 . The method of claim 1 further comprising administering one or more compounds selected from the group consisting of growth factors, cytokines, integrins cadherins, molecules or drugs that promote angiogenesis, molecules or drugs that promote vasculogenesis and molecules or drugs that promote aerteriogenesis.

13 . The method of claim 12 wherein the compound is VEGF-A, PIGF, VEGF-B, VEGF-C, VEGF-D, TGF-β, Ang-1, Ang-2, IGF, HGF, FGF, Tie2, PDGF, CCL2, Alpha-V Beta-5, Alpha-5 Beta-1, VE-cadherin, PECAM-1, plasminogen activator, or nitrogen oxide synthase.

14 . The method of claim 1 further comprising administering one or more growth factors before, during or after implanting selected stem cells in the posterior disc annulus.

15 . The method of claim 14 wherein the one or more growth factor is selected from the group consisting of: TGF-β, FGF, PDGF, and IGF.

16 . The method of claim 1 wherein the culturing of harvested stem cells is performed in a basal culture media made from a D-MEM base.

17 . A pharmaceutical composition comprising stem cells, platelets, one or more growth factors, and a pharmaceutical carrier or diluent.

18 . The composition of claim 17 wherein the stem cells are mesenchymal stem cells.

19 . The composition of claim 17 wherein the stem cells have been selected for their capacity for viability and expansion under hypoxic conditions.

20 . The compositions of claim 17 wherein the stem cells have been selected for their capacity for viability and expansion under culture conditions comparable to a damaged intervertebral disc.

21 . A method for treating an avascular zone in a patient in need thereof comprising:

harvesting stem cells from the patient in need thereof;

culturing the harvested stem cells under selective pressure that corresponds to the environment of a damaged or aged avascular zone; and

implanting the selected stem cells in the avascular zone.

22 . The method of claim 21 wherein the avascular zone is in a patient's shoulder.

23 . The method of claim 21 wherein the avascular zone is in a patient's hip.

Assignments (3)
SECURITY INTEREST Recorded Feb 25, 2020
From: BIORESTORATIVE THERAPIES, INC.
To: DESMARAIS, JOHN M.
Reel/Frame 051914/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2018
From: REGENERATIVE SCIENCES, LLC.
To: REGENEXX, LLC.
Reel/Frame 045961/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2011
From: CENTENO, CHRISTOPHER J.
To: REGENERATIVE SCIENCES, LLC
Reel/Frame 026514/0846 →